Across TCGA pan-cancer cohorts, SLC10A5P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SLC10A5P1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where SLC10A5P1 RNA is repressed in tumor relative to normal tissue. In most cancer types SLC10A5P1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA, UCEC, and HNSC are the cancer types where SLC10A5P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC10A5P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.015	.002	5	view →
UCEC	All	IV	+0.160	.015	2	view →
HNSC	Male	III,IV	+0.015	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SLC10A5P1 RNA expression & survival · all SLC10A5P1 data types